Showing results (371-380 of 528) with videos related to
Sort By:
Pageof 53
Recenti Progressi in Medicina|October 14, 2021
[Management of small cell lung cancer patient in the regions of Lazio, Umbria and Sardinia.]Gabriele Minuti, Alessio Stefani, Silvia Carpano, et al.Oncotarget|April 24, 2015
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinomaEmilio Bria, Sara Pilotto, Eliana Amato, et al.Journal of Personalized Medicine|April 3, 2021
Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective AnalysisArmando Orlandi, Letizia Pontolillo, Caterina Mele, et al.European Journal of Cancer (Oxford, England : 1990)|July 18, 2025
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinomaFilippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, et al.Frontiers in Oncology|September 26, 2022
Controversial topics in metastatic HR+/HER2- breast cancer: Guiding treatment by a modified Delphi approachAlessandra Fabi, Giuseppe Buono, Emilio Bria, et al.Plos One|November 16, 2013
Molecular typing of lung adenocarcinoma on cytological samples using a multigene next generation sequencing panelAldo Scarpa, Katarzyna Sikora, Matteo Fassan, et al.Clinical Breast Cancer|March 28, 2025
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer According to HER2 Score (Low vs. Score 0): A Retrospective StudyGiovanna Garufi, Luca Mastrantoni, Noemi Maliziola, et al.Pathology|September 5, 2014
Quantitative score modulation of HSP90 and HSP27 in clear cell renal cell carcinomaFrancesco Massari, Chiara Ciccarese, Antonio Bentito Porcaro, et al.Scientific Reports|May 10, 2018
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinomaMichele Simbolo, Caterina Vicentini, Andrea Ruzzenente, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|November 26, 2013
High-throughput mutation profiling identifies novel molecular dysregulation in high-grade intraepithelial neoplasia and early gastric cancersMatteo Fassan, Michele Simbolo, Emilio Bria, et al.Pageof 53